| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Senior Vp-corporate Operations
1 company
Cruse Michael is a Chief Operating Officer at OnKure Therapeutics, Inc.. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $47K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | OKUR Onkure Therapeutics, Inc. | Chief Operating Officer | Buy | 7,500 | $3.39 | $25,447.50 | +121.0% | -36.3% | +80.6% | |
| Aug 31, 2022 | OKUR Onkure Therapeutics, Inc. | Chief Operating Officer | Buy | 7,255 | $3.20 | $23,243.39 | +11.1% | -30.5% | +91.1% | |
| Aug 25, 2021 | OKUR Onkure Therapeutics, Inc. | Senior Vp-corporate Operations | Buy | 2,500 | $7.45 | $18,616.00 | New | +13.2% | -52.4% |